# ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens

> **NCT00335322** · PHASE4 · COMPLETED · sponsor: **Kirby Institute** · enrollment: 329 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV)

## Interventions

- **DRUG:** Truvada (fixed dose combination of tenofovir + emtricitabine) + Stocrin (efavirenz)
- **DRUG:** Truvada (fixed dose combination of tenofovir + emtricitabine)+ ritonavir/atazanavir (r/ATV)
- **DRUG:** Truvada (fixed dose combination of tenofovir + emtricitabine) + zidovudine (ZDV) + abacavir (ABC)

## Key facts

- **NCT ID:** NCT00335322
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-11
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2019-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335322, "ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00335322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*